Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver

Offering treatment with potential to cure for participants with no such offer in today's standard treatment options, by offering metastatectomia and standard treatment with intention to cure i.e., neoadjuvant chemotherapy and gastrectomy for participants with gastric- og gastroeusofageal junction cancer. Including 20 participants from all 4 centres in Denmark able to perform the surgical procedures in question. Endpoints: 2-year overall survival.

Trial Details

NCT ID
NCT06627634
Phase
NA
Sponsor
Aarhus University Hospital
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • Metastatectomia and standard treatment for resectable disease.
Locations (sample)
  • Aarhus, Jylland, Denmark|56.15674,10.21076

Key Eligibility Criteria

  • Age \> 18.
  • Presence of primary T1-T4N0-N3M1 adenocarcinoma of the stomach or GEJ and max. 30% liver involvement.
  • Primary tumour resectable, based on imaging workup.
  • Surgical operable patients with ASA-score36 ≤ III and WHO performance status37 0-1.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →